Glenmark Q4 net dips 2.5%, 1:1 bonus

BS 200 SCORECARD

Glenmark Pharmaceuticals has posted a 2.5 per cent dip in net profit for the fourth quarter ended March 31, 2005 at Rs 12.64 crore, down from Rs 12.97 crore in the corresponding period of the previous year.

Sales income in Q4 increased to Rs 139.11 crore (Rs 114.33 crore). The board of directors announced an interim dividend at 35 per cent on equity share capital of the company for FY 2004-05.

The company also allotted bonus shares in the ratio of 1:1. For the full year, the company's net profit increased to Rs 63.48 crore (Rs 42 crore). Sales income rose to Rs 536.43 crore (Rs 380.66 crore).

Provision for current and deferred taxation of Rs 23.45 crore was made for the year ended March 31, 2005. The net profit for the full year on a consolidated basis increased to Rs 109.84 crore (Rs 40.78 crore).